Molecular basis of clinical heterogeneity in neuroblastoma.

Molecular basis of clinical heterogeneity in neuroblastoma.

Item
http://www.wikidata.org/entity/Q35265996
Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous systemA single center clinical analysis of children with high-risk neuroblastoma.HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells.Insulin-like growth factor II in the pathogenesis of human neuroblastoma.Right adrenal gland neuroblastoma infiltrating the liver and mimicking mesenchymal hamartoma: A case reportHepatic metastatic disease in pediatric and adolescent solid tumors.Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathwayIs neuroblastoma screening evaluation needed and feasible?The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.Polo-like kinase 4 mediates epithelial-mesenchymal transition in neuroblastoma via PI3K/Akt signaling pathway.
P2860

Molecular basis of clinical heterogeneity in neuroblastoma.

Item
http://www.wikidata.org/entity/Q35265996
description
1992 nî lūn-bûn
@nan
1992 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Molecular basis of clinical heterogeneity in neuroblastoma.
@ast
Molecular basis of clinical heterogeneity in neuroblastoma.
@en
type
label
Molecular basis of clinical heterogeneity in neuroblastoma.
@ast
Molecular basis of clinical heterogeneity in neuroblastoma.
@en
prefLabel
Molecular basis of clinical heterogeneity in neuroblastoma.
@ast
Molecular basis of clinical heterogeneity in neuroblastoma.
@en
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P1433
P1476
Molecular basis of clinical heterogeneity in neuroblastoma.
@en
P2093
P304
P31
P433
P478
P577
P698